Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Dec 10, 2021 3:03pm
157 Views
Post# 34219793

RE:Interesting Fact

RE:Interesting FactThat will likely happen but I remain concerned that the stock has virtually no sponsorship from any broker or other source that is promoting it for the very intriguing opportunities TH has. Without sponsorship, word will be hard to get out to those portfolio managers and the stock will not reflect the value that it should. To say that the relationship the company has with the normal sponsors of a stock are epically bad, and has been for a very long time, is not an understatement. And, no matter what the company has tried to do to fix this, it seems like ti always has gotten worse. As best I can tell, Paul is not really fully aware of how bad this problemis and therefore his attention has been on fixing other problems. So, the spigot is quite smallbut there really is not enough liquidity trying to get through it to boost the stock price because we on this board are effectively the only ones paying attention to the stock. 

It is well past time for some more radical steps to be taken to see if a new course canbe charted for how TH relates to investors. Change the company name. Do a reverse stock split. Start a new approach and attitude toward investors where there is a lot of communication and transparency. Make it obvious you are working hard for shareholders. I can think of other changes but I really don't want to go there. A new page needs to be turned and it has to be really obvious to those people who typically provide sponsorship for a stock. Paul already got his feet muddy by not speaking truthfully to investors prior to the ONO and by lying about the potential revenue growth of the legacy drugs in the press release just prior to the ONO but maybe there is a chance he can still recover from that by forcefully moving in a different direction than the past IR debacles that have so undermined investor confidence in TH.  

Wino115 wrote: Stocks up around 10% from the recent low, around beginning of month, on a cumulative trading volume of around 550,000 shares. Meaning, around US$1,800,000 moved this share 10%.  That small spigot I often talk about.

My weekend thought of good cheer for you --imagine a handful of portfolio managers who understand the situation and possible financial implications wanting to establish a $5mil position early, before Phase 2 commences.  They will rush to enter the room.  What would that do? Let us dream....  Enjoy the weekend!


<< Previous
Bullboard Posts
Next >>